Exane Derivatives’s Phreesia PHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$500 Hold
20
﹤0.01% 570
2022
Q1
$527 Sell
20
-634
-97% -$19.4K ﹤0.01% 852
2021
Q4
$27.2K Buy
654
+643
+5,845% +$38.2K 0.01% 557
2021
Q3
$679 Hold
11
﹤0.01% 906
2021
Q2
$722 Hold
11
﹤0.01% 907
2021
Q1
$573 Sell
11
-194
-95% -$12.2K ﹤0.01% 784
2020
Q4
$11.1K Sell
205
-2,864
-93% -$123K ﹤0.01% 520
2020
Q3
$98.6K Buy
+3,069
New +$91.4K 0.03% 299

Other funds holding PHR

Exane Derivatives's PHR Position: Q2 2022 in Review

Exane Derivatives held its Phreesia (PHR) position steady in Q2 2022 at 20 shares worth $500. The position accounts for ﹤0.01% of the portfolio, ranked #570.

Exane Derivatives first reported a position in PHR in Q3 2020 and has held it in 8 quarters since. The position peaked at $98.6K in Q3 2020. 164 funds tracked by Wall St. Rank hold PHR as of Q2 2022.

  • Exane Derivatives held 20 shares of Phreesia worth $500 as of Q2 2022.
  • Exane Derivatives left its Phreesia share count unchanged in Q2 2022.
  • Phreesia made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #570 holding.
  • Exane Derivatives first reported a position in Phreesia in Q3 2020 and has held it in 8 quarters since.
  • Exane Derivatives's Phreesia position peaked at $98.6K in Q3 2020.
  • 164 funds tracked by Wall St. Rank held Phreesia as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.